Nanobiotix (NBTX)
NASDAQ:NBTX
Total Valuation
Nanobiotix has a market cap or net worth of $1.53B. The enterprise value is $1.37B.
Market Cap$1.53B
Enterprise Value$1.37B
Share Statistics
Nanobiotix has 48,401,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,401,120
Owned by Insiders―
Owned by Institutions11.62%
Financial Efficiency
Nanobiotix’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is -74.29%.
Return on Equity (ROE)0.28
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-74.29%
Return on Capital Employed (ROCE)-1.06
Revenue Per Employee274.47K
Profits Per Employee-221.86K
Employee Count108
Asset Turnover0.44
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nanobiotix is ―. Nanobiotix’s PEG ratio is 0.60.
PE Ratio―
PS Ratio31.74
PB Ratio-11.14
Price to Fair Value-11.14
Price to FCF-27.70
Price to Operating Cash Flow-41.74
PEG Ratio0.60
Income Statement
In the last 12 months, Nanobiotix had revenue of 29.64M and earned -23.96M in profits. Earnings per share was -0.50.
Revenue29.64M
Gross Profit29.64M
Operating Income-10.82M
Pretax Income-23.96M
Net Income-23.96M
EBITDA-12.07M
Earnings Per Share (EPS)-0.50
Cash Flow
In the last 12 months, operating cash flow was -31.13M and capital expenditures -509.00K, giving a free cash flow of -31.64M billion.
Operating Cash Flow-31.13M
Free Cash Flow-31.64M
Free Cash Flow per Share-0.65
Dividends & Yields
Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change984.77%
50-Day Moving Average28.25
200-Day Moving Average18.41
Relative Strength Index (RSI)54.46
Average Volume (3m)65.61K
Important Dates
Nanobiotix upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Nanobiotix as a current ratio of 1.09, with Debt / Equity ratio of -112.83%
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.10
Net Debt to EBITDA-3.53
Interest Coverage Ratio-1.04
Taxes
In the past 12 months, Nanobiotix has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Nanobiotix EV to EBITDA ratio is -81.50, with an EV/FCF ratio of -28.95.
EV to Sales33.18
EV to EBITDA-81.50
EV to Free Cash Flow-28.95
EV to Operating Cash Flow-29.43
Balance Sheet
Nanobiotix has $28.82M in cash and marketable securities with $51.24M in debt, giving a net cash position of -$22.42M billion.
Cash & Marketable Securities$28.82M
Total Debt$51.24M
Net Cash-$22.42M
Net Cash Per Share-$0.46
Tangible Book Value Per Share-$1.77
Margins
Gross margin is 100.00%, with operating margin of -36.49%, and net profit margin of -80.83%.
Gross Margin100.00%
Operating Margin-36.49%
Pretax Margin-80.82%
Net Profit Margin-80.83%
EBITDA Margin-40.71%
EBIT Margin-45.75%
Analyst Forecast
The average price target for Nanobiotix is $36.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$36.50
Price Target Upside11.42% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―